Educational content on VJOncology is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

GU Cancers 2025 | Examining the role of liquid biopsy in renal cell carcinoma

Chinmay Jani • 14 Feb 2025
GU Cancers 2025
Genitourinary Cancer Kidney Cancer

Chinmay Jani, MBBS, Sylvester Comprehensive Cancer Center, Doral, FL, describes a review on the evolving role of liquid biopsy in cancer diagnostics, prognostics, and treatment decision-making in renal cell carcinoma (RCC). Dr Jani highlights the potential of various liquid biopsy components, including circulating tumor DNA (ctDNA), cell-free DNA, and circulating tumor RNA (ctRNA), in detecting novel alterations and guiding personalized treatment approaches. By analyzing multiple studies, this review provides a narrative overview of current advancements and emerging platforms in liquid biopsy. This interview took place at the ASCO GU Cancers Symposium 2025 in San Francisco, CA.

These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.

More from Chinmay Jani

AI decision support in EGFR-mutant metastatic non-small cell lung cancer
3:12
AI decision support in EGFR-mutant metastatic non-small cell lung cancer
Chinmay Jani • 31 May 2026
Oncolytic virus SVV-001 plus nivolumab and ipilimumab in high-grade NENs
2:17
Oncolytic virus SVV-001 plus nivolumab and ipilimumab in high-grade NENs
Chinmay Jani • 31 May 2026
Educational impact of a guideline-based hematology-oncology bootcamp curriculum
2:41
Educational impact of a guideline-based hematology-oncology bootcamp curriculum
Chinmay Jani • 31 May 2026
Addressing the escalating impact of alcohol on cancer outcomes
1:11
Addressing the escalating impact of alcohol on cancer outcomes
Chinmay Jani • 2 Jun 2025

Related Videos

Current and emerging systemic strategies in biochemically relapsed prostate cancer
2:45
Current and emerging systemic strategies in biochemically relapsed prostate cancer
Ashwin Sachdeva • 16 May 2026
How has SABR improved radiotherapy practice in kidney cancer?
1:06
How has SABR improved radiotherapy practice in kidney cancer?
Shankar Siva • 16 May 2026
Which patients with kidney cancer may benefit from SABR treatment?
1:58
Which patients with kidney cancer may benefit from SABR treatment?
Shankar Siva • 16 May 2026
Management of brain metastasis in patients with poor-risk testicular cancer
1:03
Management of brain metastasis in patients with poor-risk testicular cancer
Darren Feldman • 30 May 2026
The content of VJOncology is intended for healthcare professionals